| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:2012.)
© 2005 American Heart Association, Inc.
Research Reports |
From the Department of Neurology, the Sarah Network of Rehabilitation Hospitals, Sarah Hospital, Brasilia DF Brazil.
Correspondence to Francisco Javier Carod-Artal, MD, PhD, Neurology Department, Sarah Hospital, SMHS Quadra 501 Conjunto A, CEP 7330-150, Brasilia DF, Brazil. E-mail javier{at}bsb.sarah.br
Background and Purpose We sought to examine ischemic stroke subtypes and prevalence of thrombophilia in Brazilian stroke patients.
Method A total of 130 consecutive young and 200 elderly stroke patients were studied.
Results Prevalence of thrombophilia was, respectively: protein S deficiency (11.5% versus 5.5%), protein C deficiency (0.76% versus 1%), resistance to activated protein C (2.3% versus 3.5%), mutation in V Leiden factor (1.5% versus 2%), antithrombin III deficiency (0% versus 0%), lupus anticoagulant (0% versus 0.5%), anticardiolipin antibodies (3% versus 10%; P=0.01), hyperhomocysteinemia (31.5% versus 53.5%; P=0.0001), mutation of the MTHFR gene in homocigosis (10% versus 5%), and heterocigosis (27.6% versus 41.9%; P=0.01).
Conclusion Prothrombotic conditions were more frequent in stroke of undetermined cause.
Key Words: epidemiology stroke thrombophilia thrombosis
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |